According to a retrospective cohort study by Elizabeth Spencer at Mount Sinai, #upadacitinib can be considered an effective maintenance treatment for pediatric patients with refractory #CrohnDisease.
#PediatricCrohnsDisease #PediatricIBD #IBDSky #GISky
@gastrotoday.bsky.social